Strengths of this study include the multicentric evaluation of blood BD-tau associations with CSF Aβ42/40, AD meta-ROI, and CSF t-tau, BD-tau and NfL in independent cohorts across the AD continuum. This evidence concerns the gene MAPT and Alzheimer disease.